Gerresheimer AG (XSWX:GXI) EPS without NRI: CHF0.63 (TTM As of Aug. 2025)


XSWX:GXI Gerresheimer AG XSWX:GXI
73 GF Score
Price CHF25.02
GF Value CHF87.96
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Gerresheimer AG EPS without NRI?

Gerresheimer AG XSWX:GXI 73 EPS without NRI is CHF0.63 as of Aug. 2025. GuruFocus rates XSWX:GXI with a GF Score™ of 73/100 and a GF Value™ of CHF87.96 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 666 Medical Devices & Instruments companies, Gerresheimer AG ranks worse than 56.31% on this metric.

Gerresheimer AG's earnings per share without non-recurring items for the three months ended in Aug. 2025 was CHF-0.35. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Aug. 2025 was CHF0.63.

During the past 12 months, Gerresheimer AG's average earnings per share (NRI) Growth Rate was -79.60% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 3.40% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Gerresheimer AG's EPS without NRI or its related term are showing as below:

XSWX:GXI' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -12.3   Med: 15.6   Max: 116.8
Current: 3.4

During the past 13 years, Gerresheimer AG's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 116.80% per year. The lowest was -12.30% per year. And the median was 15.60% per year.

XSWX:GXI's 3-Year EPS without NRI Growth Rate is ranked worse than
56.31% of 666 companies
in the Medical Devices & Instruments industry
Industry Median: 8.15 vs XSWX:GXI: 3.40

Gerresheimer AG's EPS (Diluted) for the three months ended in Aug. 2025 was CHF-0.35. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Aug. 2025 was CHF0.63.

Gerresheimer AG's EPS (Basic) for the three months ended in Aug. 2025 was CHF-0.35. Its EPS (Basic) for the trailing twelve months (TTM) ended in Aug. 2025 was CHF0.63.


Gerresheimer AG  (XSWX:GXI) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Gerresheimer AG EPS without NRI Related Terms


Gerresheimer AG EPS without NRI Historical Data

* Premium members only.

The historical data trend for Gerresheimer AG's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gerresheimer AG EPS without NRI Chart

Gerresheimer AG Annual Data
Trend Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.56 3.75 3.56 3.65 3.69

Gerresheimer AG Quarterly Data
Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.75 1.01 -0.49 0.46 -0.35

XSWX:GXI vs ISRG, BDX, MDLN: EPS without NRI Comparison

For the Medical Instruments & Supplies subindustry, Gerresheimer AG's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gerresheimer AG PE Ratio without NRI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Gerresheimer AG's PE Ratio without NRI falls into.


XSWX:GXI
73GF Score
Gerresheimer AG XSWX:GXI
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gerresheimer AG EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Aug. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF0.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of CHF0.63 mean?
Gerresheimer AG (XSWX:GXI) has a EPS without NRI of CHF0.63 as of Aug. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Gerresheimer AG and its competitors. According to the industry distribution chart, Gerresheimer AG ranks #375 out of 666 companies in the Medical Devices & Instruments industry, placing it in the top 56.3%.
Is Gerresheimer AG's EPS without NRI too high?
Gerresheimer AG's current EPS without NRI is CHF0.63. Based on the distribution chart, Gerresheimer AG ranks #375 out of 666 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Gerresheimer AG has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gerresheimer AG's EPS without NRI compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Gerresheimer AG ranks #375 out of 666 companies for EPS without NRI. This places Gerresheimer AG in the lower half of its industry. The industry median EPS without NRI is 8.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.15, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Gerresheimer AG and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gerresheimer AG's current EPS without NRI is CHF0.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gerresheimer AG stock overvalued right now?
Based on GuruFocus' analysis, Gerresheimer AG (XSWX:GXI) is currently considered Possible Value Trap. The stock's GF Value™ is CHF87.96, compared to a current price of CHF25.02 — trading 71.6% below its estimated fair value. The current EPS without NRI is CHF0.63. Gerresheimer AG's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Gerresheimer AG (XSWX:GXI), the current EPS without NRI is CHF0.63 as of Aug. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gerresheimer AG (XSWX:GXI) Overvalued in 2026?

Based on GuruFocus' analysis, Gerresheimer AG stock appears to be undervalued. The current stock price of CHF25.02 is trading 71.6% below its estimated GF Value™ of CHF87.96. GuruFocus considers Gerresheimer AG to be Possible Value Trap.

Key valuation signals for XSWX:GXI:

  • EPS without NRI: CHF0.63
  • GF Value™: CHF87.96 vs. price of CHF25.02 (71.6% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the XSWX:GXI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gerresheimer AG Business Description

Address Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
73GF Score

Get the complete analysis for XSWX:GXI

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF25.02
Price
CHF87.96
GF Value